Advisory Board

Our Board of Advisors members are among the most prominent leaders in the fields of medicine, teaching and research.

Their knowledge and access to institutions of learning and practice are helping us to develop a phenomenal Summit that will bring together some of the most high-achieving students from around the world to learn, weigh and contemplate the future of medicine.

Dr. Steve A. N. Goldstein, MA, MD, PhD, FAAP
Chairman, Global Youth Summit on Medicine Advisory Board
Dr. Goldstein graduated Phi Beta Kappa at Brandeis in 1974, earning BA and MA degrees in biochemistry. Dr. Goldstein holds an MD and PhD in immunology from Harvard University and is an accomplished scientist and scholar. He is a leading authority on mechanisms underlying normal function of the heart and brain and sudden, life-threatening diseases. Dr. Goldstein currently serves as senior vice president of Brandeis; from 2011 to 2014, Dr. Goldstein was provost at Brandeis University. Previously, Dr. Goldstein was on the faculty at the Yale University School of Medicine and founded the Section of Developmental Biology and Biophysics. In 2004, he moved to the University of Chicago to become chair of the Department of Pediatrics and Physician-in-Chief at Comer Children’s Hospital. While at Chicago he founded the Institute for Molecular Pediatric Sciences and co-founded the Institute for Translational Medicine.

Bruce Birren, PhD
Director, Genomics Sequencing Center for Infectious Diseases; and Co-Director, Genome Sequencing and Analysis Program, Broad Institute
Dr. Birren is an expert in and key contributor to many areas of genomics. He directs one of the largest programs in microbial genomics in the world, leading genome projects for bacteria, viruses, parasite and insect vectors of disease, as well research on the human microbiome. He is also the founding advisor to the Broad Institute’s Diversity Initiative in Scientific Research and oversees a number of programs dedicated to developing a new generation of leaders from under-represented minorities in genomics-related fields.

Susan Birren, PhD
Dean, College of Arts and Sciences, Brandeis University
Professor Birren, dean of Brandeis University's College of Arts and Sciences, is an internationally recognized researcher in developmental neurobiology who studies how developing nerve cells respond to the local environment to create the nervous system. Dean Birren is affiliated with the National Center for Behavioral Genomics and the Volen Center for Complex Systems. Dean Birren received her PhD in biological chemistry from the University of California at Los Angeles and did post-doctoral work at the California Institute of Technology, where she studied the cellular and molecular mechanisms underlying the development of the mammalian nervous system.

Irving R. Epstein, PhD
Henry F. Fischbach Professor of Chemistry, Brandeis University
Professor Epstein’s research focuses on oscillatory chemical reactions, spatial pattern formation, dynamical systems and neurobiology. He is the recipient of a prestigious Howard Hughes Medical Institute grant, which he used to found Brandeis’ Science Posse, a merit-based scholarship program that encourages students to pursue the sciences.

Dr. Michael Freed, MD
Cardiologist, Boston Children's Hospital
Dr. Freed has had a long and distinguished career at Boston Children’s Hospital and Harvard Medical School, where he rose to become the chief of the Division of Inpatient Cardiology. Dr. Freed chaired or served on more than two dozen committees or task forces ranging from quality improvement and patient care, to graduate medical education and governance. Dr. Freed has served on the executive committees of the American Heart Association, the American Academy of Pediatrics and the American College of Cardiology.

Dr. Eleftheria Maratos-Flier
Professor of Medicine, Harvard Medical School
Dr. Maratos-Flier is one of the world’s foremost diabetes researchers at Beth Israel Deaconess and is an expert in the role of the central nervous system in regulating feeding behavior and energy homeostasis. Her lab is focused on particular hypothalamic-striatal pathways and in particular on the role of the hormone leptin and the neuropeptide MCH in modulating motivated behavior.

Dr. Samuel Thier, MD
Professor of Medicine and Health Care Policy, Harvard Medical School
Dr. Thier serves as a Professor of Medicine and of Health at Harvard Medical School, Massachusetts General Hospital. Dr. Thier served as the Chief Executive Officer of Partners HealthCare System from 1996 to 2002. Previously, Dr. Thier was the President of Massachusetts General Hospital from 1994 to 1997 and President of Brandeis University from 1991 to 1994. He also served as the President of the Institute of Medicine, National Academy of Sciences and is a Fellow of the American Academy of Arts and Sciences. He serves as Trustee Emeritus of Cornell University and the Chairman of The Commonwealth Fund. Dr. Thier acts as a Director of the Federal Reserve Bank of Boston.